[PERSON]
Michael A. Holinstat
Featured in 1 tracked story · first seen
Situations
Sotagliflozin cardiovascular research
2 clusters · 4 sources · last updated
Latest: Diabetes research highlights new drug benefits for blood clots and glycemic control
Researchers at Michigan Medicine have identified a mechanism explaining how the diabetes medication sotagliflozin, marketed as Inpefa, reduces the risk of heart attack and stroke. Laboratory experiments published in the